Provider perceptions of telehealth and in-person exposure and response prevention for obsessive-compulsive disorder.
Provider perceptions of telehealth and in-person exposure and response prevention for obsessive-compulsive disorder.
复制标题
DOI:
10.1016/j.psychres.2022.114610
复制
发表时间:
2022-07
影响因子:
11.3
通讯作者:
Storch, Eric A.
中科院分区:
文献类型:
--
作者:
Wiese, Andrew D.;Drummond, Kendall N.;Fuselier, Madeleine N.;Sheu, Jessica C.;Liu, Gary;Guzick, Andrew G.;Goodman, Wayne K.;Storch, Eric A.
Until recently, psychotherapies, including exposure and response prevention (ERP) for obsessive–compulsive disorder (OCD), have primarily been delivered in-person. The COVID-19 pandemic required OCD providers delivering ERP to quickly transition to telehealth services. While evidence supports telehealth ERP delivery, limited research has examined OCD provider perceptions about patient characteristics that are most appropriate for this modality, as well as provider abilities to identify and address factors interfering with effective telehealth ERP. In the present study, OCD therapists (N = 113) rated the feasibility of delivering telehealth ERP relative to in-person for different (1) patient age-groups, (2) levels of OCD severity, and (3) provider ability to identify and address factors interfering with ERP during in-person and telehealth ERP (e.g., cognitive avoidance, reassurance seeking, etc.). Providers reported significantly greater feasibility of delivering telehealth ERP to individuals ages 13-to-65-years relative to other age groups assessed. Greater perceived feasibility for telehealth relative to in-person ERP was reported for lower versus higher symptom severity levels. Lastly, providers felt better able to identify and address problematic factors in-person. These findings suggest that providers should practice appropriate caution when offering telehealth ERP for certain patients with OCD. Future research may examine how to address these potential limitations of telehealth ERP delivery.
登录
查看更多内容
影响因子:
5.9
作者:
Comer JS;Furr JM;Kerns CE;Miguel E;Coxe S;Elkins RM;Carpenter AL;Cornacchio D;Cooper-Vince CE;DeSerisy M;Chou T;Sanchez AL;Khanna M;Franklin ME;Garcia AM;Freeman JB
通讯作者:
Freeman JB
影响因子:
1.1
作者:
Fletcher, Terri L.;Boykin, Derrecka M.;Hundt, Natalie E.
通讯作者:
Hundt, Natalie E.
DOI:
10.1097/chi.0b013e31816765f9
发表时间:
2008-05-01
影响因子:
13.3
作者:
Freeman, Jennifer B.;Garcia, Abbe M.;Leonard, Henrietta L.
通讯作者:
Leonard, Henrietta L.
DOI:
10.1016/j.jocrd.2021.100705
发表时间:
2022-01
影响因子:
1.8
作者:
Pinciotti CM;Bulkes NZ;Horvath G;Riemann BC
通讯作者:
Riemann BC
影响因子:
7.4
作者:
McGuire JF;Piacentini J;Lewin AB;Brennan EA;Murphy TK;Storch EA
通讯作者:
Storch EA